Steven R. Pacelli - Oct 22, 2021 Form 4 Insider Report for DEXCOM INC (DXCM)

Role
Managing Dir., Dexcom Ventures
Signature
By: Jereme Sylvain For: Steven R Pacelli
Stock symbol
DXCM
Transactions as of
Oct 22, 2021
Transactions value $
-$142,500
Form type
4
Date filed
10/25/2021, 07:35 PM
Previous filing
Sep 24, 2021
Next filing
Nov 23, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DXCM Common Stock Sale -$143K -250 -0.61% $570.00 40.8K Oct 22, 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On June 14, 2021, Mr. Pacelli adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli. The shares set forth above were sold pursuant to the 10b5-1 Plan.
F2 Included in this number are 13,673 unvested restricted stock units, 5,301 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 2,498 of which were granted on March 8, 2019 and shall vest through March 8, 2022.